SCHEMBL7708477

SCHEMBL7708477

Nc1ncc(CCc2ccccc2)c(N2CCOCC2)n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGMT P16455 1/20 0.48
PIK3CA P42336 4/20 0.48
AKT1 P31749 2/20 0.48
NOS1 P29475 1/20 0.48
OGA O60502 1/20 0.44
ALDH1A1 P00352 3/20 0.44
ALOX15 P16050 2/20 0.44
HSD17B10 Q99714 2/20 0.44
TSHR P16473 1/20 0.44
MAPK1 P28482 1/20 0.44
PIK3CB P42338 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
CREBBP Q92793 1/20 0.44
ACHE P22303 1/20 0.44
POLB P06746 1/20 0.43
HPGD P15428 1/20 0.43
MTOR P42345 2/20 0.43
PIK3R1 P27986 1/20 0.43
GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7708556 0.93 MGMT (0.47) MGMTPIK3CAAKT1NOS1OGA
SCHEMBL7714543 0.88 PIK3CA (0.55) MGMTPIK3CAAKT1NOS1ALDH1A1
SCHEMBL7711748 0.86 ALDH1A1 (0.54) ALDH1A1ALOX15HSD17B10TSHRMAPK1
SCHEMBL7711799 0.85 OGA (0.47) OGAALDH1A1ALOX15HSD17B10TSHR
SCHEMBL7708590 0.85 MAPT (0.47) OGAALDH1A1ALOX15HSD17B10TSHR
SCHEMBL7714594 0.84 NOS1 (0.53) PIK3CANOS1ALDH1A1HSD17B10RAB9A
SCHEMBL8139605 0.81 TSHR (0.50) MGMTPIK3CAAKT1NOS1ALDH1A1
SCHEMBL8139048 0.80 PIK3CA (0.47) MGMTPIK3CAAKT1NOS1ALDH1A1
SCHEMBL7708555 0.79 GAA (0.50) OGAALDH1A1ALOX15HSD17B10TSHR
SCHEMBL7712443 0.79 MGMT (0.58) MGMTPIK3CAAKT1NOS1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP claimed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO claimed
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US disclosed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP disclosed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO disclosed